Pamela Kunz, MD | Authors


Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future

November 03, 2015

Pamela Kunz, MD, assistant professor, Division of Oncology, Stanford University School of Medicine, talks about the findings of the phase II study of everolimus plus bevacizumab in pNETs, as well as bevacizumab in progressive pNETS.